Skip to Main Content


Here you will find coverage of psychedelic drugs, which are drawing enormous interest as possible treatments for mental illnesses such as depression, post-traumatic stress disorder (PTSD), and anxiety. Long-stigmatized drugs such as psilocybin and MDMA are moving through clinical trials, and the anesthetic ketamine has gained popularity as a treatment for serious depression in combination with psychotherapy.